Page last updated: 2024-09-02

2-hydroxyimipramine and Depression, Involutional

2-hydroxyimipramine has been researched along with Depression, Involutional in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiba, K; Ishizaki, T; Kawakatsu, S; Koyama, E; Kubota, T; Morinobu, S; Tanaka, T; Totsuka, S	1

Other Studies

1 other study(ies) available for 2-hydroxyimipramine and Depression, Involutional

Article	Year
Effects of genetic defects in the CYP2C19 gene on the N-demethylation of imipramine, and clinical outcome of imipramine therapy. Psychiatry and clinical neurosciences, 1997, Volume: 51, Issue:4 Topics: Adult; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Depressive Disorder, Major; DNA Mutational Analysis; Dose-Response Relationship, Drug; Exons; Female; Genetic Carrier Screening; Genotype; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Treatment Outcome	1997

Article

Year

Effects of genetic defects in the CYP2C19 gene on the N-demethylation of imipramine, and clinical outcome of imipramine therapy.

Psychiatry and clinical neurosciences, 1997, Volume: 51, Issue:4

Topics: Adult; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Depressive Disorder, Major; DNA Mutational Analysis; Dose-Response Relationship, Drug; Exons; Female; Genetic Carrier Screening; Genotype; Humans; Imipramine; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Treatment Outcome

1997